Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy

DOI10.1111/BIOM.12016MaRDI QIDQ77966zbMATHOpenAlexWikidataFDO

Authors M. Juraska, Peter B. Gilbert

Publication date 19 February 2013

Published in Biometrics (Search for Journal in Brave)

Full work available at URL http://europepmc.org/articles/pmc3940058

zbMATH Keywords

competing risksCox regression modeldensity ratio modelfailure time datagenetic datamark variablemark-specific vaccine efficacy

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Mark-specific hazard ratio model with missing multivariate marks
• Proportional hazards models with continuous marks
• The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
• Estimation of stratified mark-specific proportional hazards models with missing marks
• Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark

Cites work

• A Bootstrap Revival of Some Nonparametric Distance Tests
• A goodness-of-fit test for logistic regression models based on case-control data
• An improved Bonferroni procedure for multiple tests of significance
• Improving the efficiency of the log-rank test using auxiliary covariates
• Inferences for case-control and semiparametric two-sample density ratio models
• Large sample theory of maximum likelihood estimates in semiparametric biased sampling models.
• Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials
• Nonparametric estimation of the joint distribution of survival time and mark variables
• Proportional hazards models with continuous marks
• Proportional hazards tests and diagnostics based on weighted residuals
• The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
• The Analysis of Failure Times in the Presence of Competing Risks

Cited in

(16)

• The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
• Leaky vaccines protect highly exposed recipients at a lower rate: implications for vaccine efficacy estimation and sieve analysis
• Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trials
• Statistical Methods for Assessing Differential Vaccine Protection Against Human Immunodeficiency Virus Types
• Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark
• Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy
• Mark-specific additive hazards regression with continuous marks
• Proportional hazards models with continuous marks
• Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiation
• A unified evaluation of differential vaccine efficacy
• Hypotheses tests of strain-specific vaccine efficacy adjusted for covariate effects
• sievePH
• Estimation of stratified mark-specific proportional hazards models with missing marks
• Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated
• Testing and Estimation of Time‐Varying Cause‐Specific Hazard Ratios with Covariate Adjustment
• Mark-specific hazard ratio model with missing multivariate marks

This page was built for publication: Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q77966)